---
title: "688765.SH (688765.SH) — 相关新闻"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/688765.SH/news.md"
symbol: "688765.SH"
name: "688765.SH"
parent: "https://longbridge.com/zh-CN/quote/688765.SH.md"
datetime: "2026-03-17T08:04:45.243Z"
locales:
  - [en](https://longbridge.com/en/quote/688765.SH/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688765.SH/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688765.SH/news.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/688765.SH/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/688765.SH/news.md)


# 688765.SH (688765.SH) — 相关新闻

### [Healthgen Biotechnology's first year of listing: cutting-edge technology supports a market value of over 20 billion yuan, yet struggles to hide the issue of losses](https://longbridge.com/zh-CN/news/279118656.md)
*2026-03-14T10:03:13.000Z*
> Healthgen Biotechnology achieved operating revenue of CNY 47.8614 million in its first year of listing, a year-on-year i

### [Healthgen Biotechnology collaborates with PerkinElmer to develop precision therapies for cancer](https://longbridge.com/zh-CN/news/278360921.md)
*2026-03-09T09:06:05.000Z*
> HeRong Technology and Peier Biomedical signed a strategic alliance letter of intent, planning to jointly develop the com

### [Intraday News - ShiHe (3551) surged 3.01% to NT$188.5, with a trading volume of 275 shares](https://longbridge.com/zh-CN/news/277858856.md)
*2026-03-05T01:31:41.000Z*
> Shihe (3551-TW) stock price rose 3.01% at 09:31 on the 5th, reporting NT$188.5, with a trading volume of 275 shares, and

### [Revenue surged by 89.80%! Healthgen Biotechnology achieved innovative acceleration in its first year of listing?](https://longbridge.com/zh-CN/news/277710805.md)
*2026-03-04T02:12:42.000Z*
> Healthgen Biotechnology (688765) released its performance preliminary report for 2025, with revenue reaching 47.8614 mil

### [Healthgen Biotechnology's net loss attributable to the parent for the fiscal year 2025 is 158 million yuan](https://longbridge.com/zh-CN/news/277019087.md)
*2026-02-26T10:01:06.000Z*
> Healthgen Biotechnology released its performance preliminary report for the year 2025, with total operating revenue of 4

### [Aiming at the hundred billion-level import substitution market to accelerate the industrialization breakthrough of "rice blood production"](https://longbridge.com/zh-CN/news/275384807.md)
*2026-02-10T01:14:20.000Z*
> On October 28, 2025, Healthgen Biotechnology (688765) successfully landed on the Sci-Tech Innovation Board, becoming the

### [The funds frozen in the Bio Valley capital occupation case are efficiently returned to the listed company](https://longbridge.com/zh-CN/news/275189125.md)
*2026-02-07T02:25:36.000Z*
> Recently, the Beijing Stock Exchange listed company Bio Valley (920266) announced that progress has been made in the rec

### [Intraday News - Shuohe (3691) surged 7.33%, reported at 124.5 yuan](https://longbridge.com/zh-CN/news/274737001.md)
*2026-02-04T01:14:41.000Z*
> ShuoHe (3691-TW) stock price rose by 7.33%, closing at NT$ 124.5, with a trading volume of 751 lots. Despite a 12.12% de

### [Taiwan stock market dynamics: NVIDIA expands headquarters, EVA Air undergoes digital transformation, mobile phone sales continue to decline](https://longbridge.com/zh-CN/news/274249980.md)
*2026-01-30T04:40:05.000Z*
> Taiwan stock market dynamics: Nvidia plans to establish a second headquarters in Taipei City, demonstrating its emphasis